Dr. Lal Path Labs Ltd.

Web: lalpathlabs.com NSE: LALPATHLAB BSE: 539524 SECTOR: Healthcare - Healthcare Services | Add Note | View Notes

1875 50(-3%)

Near 52W High of 1989

Volume

2L as on 03, Sep

Open

2,900

High

2,958

Low

2,931

1,925

VWAP

1,921

52 Week High

1,989

52 Week Low

1,273

Viand Research Rating

Quality Score

76/100

Growth Score

44/100

Valuation Score

50/100

Momentum Score

70/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

31,475

No. of Shares

16.8

P/E

57.13

P/B

12.01

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

21.01

ROCE

Profit Growth

Listing Date

23-Dec-15

Promoter Holding

53.19%

FII Holding

17.35%

DII Holding

21.59%

Price Chart

Price Performance

1 Week0%

1 Month1%

3 Months23%

6 Months37%

1 Year42%

YTD28%

Moving Average

5 Day SMA1,923

10 Day SMA1,918

20 Day SMA1,920

30 Day SMA1,902

50 Day SMA1,815

61 Day SMA1,783

80 Day SMA1,740

200 Day SMA1,557

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	1,976	1,927	1,955	1,988
Resistance 2	1,955	1,924	1,939	1,961
Resistance 1	1,935	1,920	1,930	1,947
Pivot Point	1,914	1,916	1,914	1,920
Support 1	1,895	1,912	1,899	1,907
Support 2	1,874	1,909	1,889	1,880
Support 3	1,854	1,905	1,874	1,866

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 53.19%	(0.01) 53.21%	(0.01) 53.21%	(-0.61) 53.21%	(-0.11) 53.79%	(0.01) 53.91%	(0.01) 53.91%	(-0.71) 53.92%	(0.01) 54.60%	(0.01) 54.60%	(0.01) 54.60%	(-0.41) 54.61%	(0.01) 55.01%	(0.01) 55.03%	(0.01) 55.04%	(0.01) 55.04%	(-0.21) 55.05%	(0.01) 55.23%	(0.01) 55.23%	(0.01) 55.23%
FIIs	(0.21) 17.35%	(-3.11) 17.18%	(-1.61) 20.29%	(0.21) 21.86%	(-2.21) 21.69%	(-2.91) 23.90%	(0.01) 26.82%	(1.41) 26.82%	(-0.71) 25.43%	(0.81) 26.15%	(1.01) 25.36%	(1.11) 24.35%	(-1.61) 23.27%	(-0.91) 24.89%	(2.51) 25.80%	(0.91) 23.26%	(-1.11) 22.37%	(-2.01) 23.44%	(-1.41) 25.45%	(0.01) 26.82%
DIIs	(0.21) 21.59%	(2.21) 21.37%	(1.01) 19.20%	(0.61) 18.22%	(1.81) 17.62%	(2.91) 15.79%	(0.31) 12.88%	(0.21) 12.60%	(3.01) 12.42%	(0.11) 9.40%	(0.41) 9.27%	(0.51) 8.85%	(1.81) 8.34%	(0.41) 6.56%	(-0.11) 6.20%	(-0.31) 6.27%	(-0.31) 6.52%	(0.31) 6.83%	(0.81) 6.57%	(0.01) 5.73%
Government	0.01%	0.01%	0.01%	0.27%	0.29%	0.29%	0.29%	0.29%	0.29%	0.29%	0.29%	0.29%	0.29%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	7.48%	7.88%	6.94%	6.07%	6.22%	5.84%	5.82%	6.02%	6.95%	9.24%	10.12%	11.48%	12.65%	13.01%	12.38%	14.84%	15.46%	13.80%	12.01%	11.42%
No. of Shareholders	111,037	114,527	116,167	112,703	118,656	115,699	116,236	116,606	131,189	146,741	149,901	160,679	174,444	180,163	179,636	171,602	184,508	171,846	135,068	125,953

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	798	703	660	731	670	603	597	660	602	545	539	601	541	491	489	534	503	486	497	498	607
Sales Growth % (YoY)	19.1%	16.6%	10.6%	10.7%	11.3%	10.5%	10.7%	9.8%	11.3%	11.1%	10.1%	12.6%	7.6%	1.1%	-1.5%	7.1%	-17.1%	12.6%	9.8%	15.4%	128%
Sales Growth % (QoQ)	13.5%	6.5%	-9.7%	9.1%	11.1%	1%	-9.5%	9.6%	10.5%	1.1%	-10.3%	11.1%	10.2%	0.4%	-8.4%	6.2%	3.5%	-2.2%	-0.2%	-18%	-
Expenses	550	516	480	506	478	434	443	458	432	401	398	424	395	375	376	390	385	364	388	357	418
Operating Profit	248	187	179	224	192	169	154	202	170	145	141	178	146	116	113	144	118	121	109	142	189
OPM %	31	27	27	31	29	28	26	31	28	27	26	30	27	24	23	27	23	25	22	28	31
Other Income	32	24	-6	25	28	26	25	22	21	18	18	18	14	14	10	9	8	12	12	14	14
Interest	6	6	7	5	5	5	5	6	6	7	7	8	8	9	9	11	8	12	9	5	5
Depreciation	44	45	42	40	35	36	36	35	35	37	36	36	35	38	38	39	36	38	31	20	19
Profit before tax	229	160	124	204	181	153	138	183	150	120	116	152	118	83	76	103	81	84	82	131	179
Tax %	25	17	26	25	26	-1	29	29	28	28	29	27	29	32	30	30	28	26	29	26	25
Net Profit	170	132	91	152	134	156	98	131	108	86	82	111	84	57	54	72	58	62	58	96	134
Net Profit Growth % (QoQ)	28.8%	45.1%	-40.1%	13.4%	-14.1%	59.2%	-25.2%	21.3%	25.6%	4.9%	-26.1%	32.1%	47.4%	5.6%	-25%	24.1%	-6.5%	6.9%	-39.6%	-28.4%	-
Net Profit Growth % (YoY)	26.9%	-15.4%	-7.1%	16%	24.1%	81.4%	19.5%	18%	28.6%	50.9%	51.9%	54.2%	44.8%	-8.1%	-6.9%	-25%	-56.7%	-	-	-	-
TTM Net Profit	545	509	533	540	519	493	423	407	387	363	334	306	267	241	246	250	274	350	288	230	0
EPS in Rs	10.11	7.84	5.4	8.99	7.9	9.26	5.78	7.73	6.37	5.06	4.87	6.55	4.95	3.4	3.17	4.3	6.92	7.35	6.88	11.4	15.74

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	2763	2461	2227	2017	2087	1581	1330	1203	1057	912	791	660	558	452
Sales Growth %	12.2%	10.5%	10.4%	-3.4%	32%	18.9%	10.6%	13.9%	15.8%	15.3%	20%	18.2%	23.5%	32%
Expenses	1979	1764	1617	1527	1526	1145	987	910	793	675	582	504	419	354
Operating Profit	783	698	609	490	561	436	344	294	264	238	210	156	139	98
OPM %	28	28	27	24	27	28	26	24	25	26	26	24	25	22
Other Income	70	91	69	42	52	51	55	46	31	27	20	12	8	3
Interest	23	22	29	38	30	16	15	1	1	1	0	0	0	0
Depreciation	162	142	144	150	108	77	73	38	33	28	28	28	27	20
Profit before tax	669	625	505	344	475	394	310	301	261	237	201	140	119	80
Tax %	24	21	28	30	26	25	27	33	34	34	34	31	33	31
Net Profit	510	492	362	241	350	296	228	200	172	156	133	96	80	55
Net Profit Growth %	3.7%	35.9%	50.2%	-31.1%	18.2%	29.8%	14%	16.3%	10.3%	17.3%	38.5%	20%	45.5%	-
EPS in Rs	30.13	29.14	21.42	14.33	20.69	17.49	13.55	11.95	10.24	9.31	7.99	8.75	74.38	1643.22
Dividend Payout %	68	41	0	42	29	57	44	25	22	16	15	9	7	9

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	636	569	535	456	447	398	284	219	197	171	159	122	98	88
Cash from Investing Activity	-422	-303	-24	-287	-449	-212	-26	-100	-172	-137	-163	-113	-89	-64
Cash from Financing Activity	-264	-334	-414	-283	136	-139	-190	-55	13	-32	0	-1	-10	-15
Net Cash Flow	-50	-68	97	-114	134	48	67	64	37	2	-5	8	-2	9

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	168	84	84	84	83	83	83	83	83	83	83	83	83	55	54	3
Reserves	2341	2304	2089	1918	1766	1583	1418	1162	949	862	705	512	425	260	151	157
Borrowings	199	156	157	198	247	420	533	150	0	0	0	0	0	27	28	2
Other Liabilities	433	415	383	397	357	297	309	265	341	145	128	95	118	134	119	106
Total Liabilities	3140	2959	2713	2598	2454	2383	2343	1661	1374	1091	916	690	625	475	352	269
Fixed Assets	1256	1232	1168	1189	1228	1305	1369	447	413	209	208	152	166	150	140	127
CWIP	7	17	3	1	6	5	15	10	11	3	10	18	4	1	0	1
Investments	423	486	327	289	114	150	65	59	164	185	145	106	64	38	9	55
Other Assets	1454	1225	1215	1119	1107	923	893	1144	786	694	554	414	391	286	203	87
Total Assets	3140	2959	2713	2598	2454	2383	2343	1661	1374	1091	916	690	625	475	352	269

Delivery

Delivery Data: LALPATHLAB

#	Date	1610 24% 1989	Value (Cr)	Q/T 11	Del 52	Del 57
1	4-Sep	1878	54	7	52	28
2	3-Sep	1925	32	6	65	21
3	2-Sep	1916	34	8	60	20
4	1-Sep	1904	89	18	41	36
5	31-Aug	1935	30	8	58	17
6	28-Aug	1931	17	3	60	11
7	27-Aug	1936	17	4	57	10
8	26-Aug	1937	26	5	52	14
9	25-Aug	1914	37	6	53	20
10	24-Aug	1884	28	5	57	16
11	21-Aug	1894	19	5	48	9
12	20-Aug	1889	58	7	58	34
13	19-Aug	1887	30	7	69	21
14	18-Aug	1901	40	9	54	22
15	17-Aug	1877	26	6	42	11
16	14-Aug	1916	44	9	55	24
17	13-Aug	1968	40	9	69	28
18	12-Aug	1953	69	10	65	45
19	11-Aug	1950	39	5	67	26
20	10-Aug	1954	57	10	51	29
21	7-Aug	1932	31	10	63	19
22	6-Aug	1928	82	12	60	49
23	5-Aug	1887	60	7	58	35
24	4-Aug	1889	96	12	59	57
25	3-Aug	1900	137	13	67	92
26	31-Jul	1905	67	7	58	39
27	30-Jul	1879	115	16	62	72
28	29-Jul	1882	195	16	54	105
29	28-Jul	1805	69	16	67	46
30	27-Jul	1827	392	16	26	101
31	24-Jul	1759	248	11	36	88
32	23-Jul	1687	25	6	63	16
33	22-Jul	1699	31	5	60	18
34	21-Jul	1700	24	8	66	16
35	20-Jul	1693	36	9	60	21
36	17-Jul	1687	36	7	46	17
37	16-Jul	1733	36	7	58	21
38	15-Jul	1723	54	12	53	29
39	14-Jul	1745	50	10	58	29
40	13-Jul	1725	57	11	54	31
41	10-Jul	1693	35	11	60	21
42	9-Jul	1685	43	13	64	27
43	8-Jul	1654	31	9	46	14
44	7-Jul	1681	93	12	65	60
45	6-Jul	1686	134	17	78	104
46	3-Jul	1646	82	14	76	62
47	2-Jul	1650	40	9	58	23
48	1-Jul	1623	32	7	56	18
49	30-Jun	1646	70	12	59	42
50	29-Jun	1647	87	8	57	50

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	31,475c	722c	2.24
03-Sep	32,197c	384c	1.21
01-Sep	31,812c	129c	0.40
31-Aug	31,942c	539c	1.66
27-Aug	32,480c	77c	0.24
26-Aug	32,558c	969c	3.07
25-Aug	31,589c	285c	0.90
24-Aug	31,875c	235c	0.74
21-Aug	31,640c	8c	0.03
19-Aug	31,631c	160c	0.50
18-Aug	31,791c	409c	1.30
17-Aug	31,382c	637c	1.99
14-Aug	32,019c	907c	2.75
13-Aug	32,926c	236c	0.72
12-Aug	32,689c	82c	0.25
11-Aug	32,607c	0	0
10-Aug	32,607c	337c	1.04
07-Aug	32,270c	295c	0.91
06-Aug	32,565c	1,056c	3.35
05-Aug	31,509c	144c	0.46
04-Aug	31,365c	498c	1.56
03-Aug	31,863c	12c	0.04
31-Jul	31,851c	84c	0.26
30-Jul	31,767c	112c	0.35
29-Jul	31,655c	1,396c	4.61
28-Jul	30,259c	252c	0.82
27-Jul	30,510c	754c	2.54
24-Jul	29,756c	0	0

Stock Checklist

Price is above from 52 week high low average: 84%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView